ProfileGDS4132 / 228461_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 88% 86% 89% 89% 90% 84% 89% 88% 89% 90% 87% 83% 90% 87% 85% 80% 84% 82% 82% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101369.74788
GSM201543Muscle PCOS pioglitazone 121314.81386
GSM201544Muscle PCOS pioglitazone 161443.71489
GSM201545Muscle PCOS pioglitazone 201428.91889
GSM201829Muscle PCOS pioglitazone 231436.72590
GSM201830Muscle PCOS pioglitazon 251318.93384
GSM201831Muscle PCOS pioglitazone 271416.29589
GSM201832Muscle PCOS pioglitazone 31381.16188
GSM201833Muscle PCOS pioglitazone 41409.54989
GSM201834Muscle PCOS pioglitazone 81438.30290
GSM201835Muscle PCOS after pioglitazone 102378.787
GSM201836Muscle PCOS after pioglitazone 122308.51283
GSM201837Muscle PCOS after pioglitazone 162434.10290
GSM201838Muscle PCOS after pioglitazone 202394.14987
GSM201839Muscle PCOS after pioglitazone 232346.90385
GSM201840Muscle PCOS after pioglitazone 252296.41980
GSM201841Muscle PCOS after pioglitazone 272316.42384
GSM201842Muscle PCOS after pioglitazone 32276.05582
GSM201843Muscle PCOS after pioglitazone 42298.06382
GSM201844Muscle PCOS after pioglitazone 82351.90485